Snowball logo
logo
IZO

Izotropic Corporation

IZO CN
CA$0.24+CA$0.01  (4.35%)
Estimate
EPS
-0.03
Beta
2.431
Growth
Net income, YoY
24.1%
FCF, YoY
-90.37%
About the company
Ticker
IZO
ISIN
Country
Canada
Sector (GICS)
Healthcare
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

Frequently asked questions

What sector does Izotropic Corporation (IZO) operate in?

Izotropic Corporation belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Izotropic Corporation (IZO) current stock price?

As of the latest data, Izotropic Corporation stock price is CA$0.24, with a previous close of CA$0.23. Izotropic Corporation gained CA$0.01 in the last trading session, representing a 4.35% increase.

What is Izotropic Corporation (IZO) current market capitalization?

Izotropic Corporation market cap is approximately 16.56 million.

What is Izotropic Corporation (IZO) Earnings Per Share (EPS)?

The trailing EPS is -CA$0.03.

Does Izotropic Corporation (IZO) pay dividends?

No. Izotropic Corporation does not pay a dividend.

What is Izotropic Corporation (IZO) beta (volatility) score?

Izotropic Corporation has a beta of 2.431, indicating very high volatility compared to the market.